These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 6189605

  • 1. Disposition of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-phosphate in mice and dogs.
    Noker PE, Duncan GF, El Dareer SM, Hill DL.
    Cancer Treat Rep; 1983 May; 67(5):445-56. PubMed ID: 6189605
    [Abstract] [Full Text] [Related]

  • 2. Disposition of 9-beta-D-arabinofuranosyl-2-fluoroadenine in mice, dogs, and monkeys.
    El Dareer SM, Struck RF, Tillery KF, Rose LM, Brockman RW, Montgomery JA, Hill DL.
    Drug Metab Dispos; 1980 May; 8(2):60-3. PubMed ID: 6103788
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Physiological disposition of 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine in humans.
    Kreis W, Gordon CS, DeJager R, Krakoff IH.
    Cancer Res; 1975 Sep; 35(9):2453-60. PubMed ID: 1149046
    [Abstract] [Full Text] [Related]

  • 5. Disposition of indicine N-oxide in mice and monkeys.
    El Dareer SM, Tillery KF, Lloyd HH, Hill DL.
    Cancer Treat Rep; 1982 Jan; 66(1):183-6. PubMed ID: 7053256
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic and metabolism studies of two novel 1-deaza-7,8-dihydropteridines in mice.
    Noker PE, Hill DL, Kalin JR, Temple CG, Montgomery JA.
    Drug Metab Dispos; 1985 Jan; 13(6):677-81. PubMed ID: 2867870
    [Abstract] [Full Text] [Related]

  • 7. Metabolism of 9-beta-D-arabinosyl-2-fluoroadenine-5'-phosphate by mice bearing P388 leukemia.
    Avramis VI, Plunkett W.
    Cancer Drug Deliv; 1983 Jan; 1(1):1-10. PubMed ID: 6085754
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of 2-F-ara-A (9-beta-D-arabinofuranosyl-2-fluoroadenine) in cancer patients during the phase I clinical investigation of fludarabine phosphate.
    Malspeis L, Grever MR, Staubus AE, Young D.
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):18-32. PubMed ID: 1699279
    [Abstract] [Full Text] [Related]

  • 9. Disposition of thymidine administered as large doses to rats and mice.
    Hill DL, Noker PE, Duncan GF, El Dareer SM.
    Cancer Treat Rep; 1981 Oct; 65(5-6):495-9. PubMed ID: 7237470
    [Abstract] [Full Text] [Related]

  • 10. Disposition of 5-methyltetrahydrohomofolate in mice, dogs, and monkeys.
    El Dareer SM, Tillery KF, Hill DL.
    Cancer Treat Rep; 1979 Feb; 63(2):201-7. PubMed ID: 109197
    [Abstract] [Full Text] [Related]

  • 11. NTP Toxicology and Carcinogenesis Studies of para-Chloroaniline Hydrochloride (CAS No. 20265-96-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1989 Jul; 351():1-256. PubMed ID: 12704433
    [Abstract] [Full Text] [Related]

  • 12. Plasma and tissue levels of furosemide in dogs and monkeys following single and multiple oral doses.
    Yakatan GJ, Maness DD, Scholler J, Johnston JT, Novick WJ, Doluisio JT.
    Res Commun Chem Pathol Pharmacol; 1979 Jun; 24(3):465-82. PubMed ID: 109903
    [Abstract] [Full Text] [Related]

  • 13. Metabolism and therapeutic efficacy of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia P388.
    Avramis VI, Plunkett W.
    Cancer Res; 1982 Jul; 42(7):2587-91. PubMed ID: 7083151
    [Abstract] [Full Text] [Related]

  • 14. Distribution and metabolism of prednisone in mice, dogs, and monkeys.
    El Dareer SM, Struck RF, White VM, Mellett LB, Hill DL.
    Cancer Treat Rep; 1977 Oct; 61(7):1279-89. PubMed ID: 412589
    [Abstract] [Full Text] [Related]

  • 15. Identification of metabolites of 9-beta-D-arabinofuranosyl-2-fluoroadenine, an antitumor and antiviral agent.
    Struck RF, Shortnacy AT, Kirk MC, Thorpe MC, Brockman RW, Hill DL, El Dareer SM, Montgomery JA.
    Biochem Pharmacol; 1982 Jun 01; 31(11):1975-8. PubMed ID: 7115418
    [Abstract] [Full Text] [Related]

  • 16. Antitumor activity of 2-fluoro-2'-deoxyadenosine against tumors that express Escherichia coli purine nucleoside phosphorylase.
    Parker WB, Allan PW, Hassan AE, Secrist JA, Sorscher EJ, Waud WR.
    Cancer Gene Ther; 2003 Jan 01; 10(1):23-9. PubMed ID: 12489025
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics and metabolism in mice of a phosphorothioate oligonucleotide antisense inhibitor of C-raf-1 kinase expression.
    Geary RS, Leeds JM, Fitchett J, Burckin T, Truong L, Spainhour C, Creek M, Levin AA.
    Drug Metab Dispos; 1997 Nov 01; 25(11):1272-81. PubMed ID: 9351904
    [Abstract] [Full Text] [Related]

  • 18. Disposition and metabolism of carbovir in mice dosed intravenously or orally.
    el Dareer SM, Tillery KF, Rose LM, Struck RF, Hill DL.
    Drug Metab Dispos; 1990 Nov 01; 18(6):842-5. PubMed ID: 1981526
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of G3139, a phosphorothioate oligodeoxynucleotide antisense to bcl-2, after intravenous administration or continuous subcutaneous infusion to mice.
    Raynaud FI, Orr RM, Goddard PM, Lacey HA, Lancashire H, Judson IR, Beck T, Bryan B, Cotter FE.
    J Pharmacol Exp Ther; 1997 Apr 01; 281(1):420-7. PubMed ID: 9103525
    [Abstract] [Full Text] [Related]

  • 20. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T, Nakajima Y, Mizobuchi M, Inazawa K, Kanazu T, Kadono K, Ohkawa T, Iwatani K.
    Arzneimittelforschung; 1998 Oct 01; 48(10):995-1006. PubMed ID: 9825117
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.